Rupatch 10mcg Transdermal Patch

By Rupatch

Rx

2es Transdermal Patch in a Packet

Composition icon

Composition

Buprenorphine(10mcg)

Manufacturer - Rusan Pharma Ltd icon

Manufacturer - Rusan Pharma Ltd

58-D, Government Industrial Estate, Charkop, Kandivli (W), Mumbai – 400 067 (India).

Expires on or after icon

Expires on or after

September, 2025

About Rupatch 10mcg Transdermal Patch

Rupatch 10mcg Transdermal Patch is a medication used for managing moderate to severe pain and for addressing opioid dependence or addiction. It is particularly helpful in preventing withdrawal symptoms that can occur when switching from other opioids.

Your doctor will provide detailed instructions on how to use Rupatch 10mcg Transdermal Patch. It's important to follow these instructions carefully to ensure maximum benefit. The dosage and duration of treatment will vary based on your individual condition and response to the medication. Consistent use is crucial, and discontinuation should only be done under your doctor's guidance.

Like any medication, Rupatch 10mcg Transdermal Patch may cause side effects. Common side effects include constipation, dizziness, drowsiness, headache, and nausea. These side effects are more likely to occur when starting the treatment or when the dosage is increased. Typically, they diminish over time as your body adjusts. Should the side effects persist or worsen, it's necessary to remove the patch and seek medical advice.

Before using Rupatch 10mcg Transdermal Patch, inform your doctor about any existing illnesses or disorders. Certain medications may interact with Rupatch 10mcg Transdermal Patch, so it's important to disclose all other medications you are currently taking. Pregnant and breastfeeding women should consult their healthcare providers before using this medication.

Rupatch 10mcg Transdermal Patch contains Buprenorphine, an opioid partial agonist-antagonist that falls under the class of drugs known as opioid analgesics. It acts by blocking pain-causing chemical messengers in the brain, providing relief by targeting specific brain receptors. This medication is primarily used to treat severe pain, whether it is temporary (acute) or long-lasting (chronic) in nature.

Side effects of Rupatch 10mcg Transdermal Patch may include drowsiness, dry mouth, vomiting, blurred vision, constipation, dizziness, tiredness, or skin reactions. These side effects are usually temporary and do not require medical intervention. However, if they persist or worsen, consulting your doctor is advisable.

It is important to note that Rupatch 10mcg Transdermal Patch is not suitable for individuals allergic to it, its ingredients, or opioids in general. Pregnant or breastfeeding women, as well as individuals under 18 years of age, should avoid using this medication. Due to the risk of dependency, it should not be discontinued without medical guidance, as abrupt cessation may lead to withdrawal symptoms. Alcohol consumption while using Rupatch 10mcg Transdermal Patch should be avoided to minimize the risk of potential side effects.


Disclaimer

The information provided on this website is to the best of our abilities to ensure it is accurate, reliable, and reviewed by a team of professionals. It should not be used to diagnose, prevent, or cure any health problem. The information presented here is not intended to create a doctor-patient relationship or replace a registered medical practitioner's advice, diagnosis, or treatment. The absence or provision of any information or warning regarding any medicine should not be assumed as an implied or explicit assurance of safety or efficacy. We highly recommend consulting your registered medical practitioner for all queries or doubts related to your medical condition. Do not ignore professional medical advice or delay seeking it based on the content encountered on our website. We intend to support, not replace, the doctor-patient relationship.

1050.5

Inclusive of all taxes

Content verified by

chevron-right

Dr. Archana Prabhakar

MBBS, M.Med (Family Medicine)

Last update on 07-Oct-2024